Loading data for CORT — first visit, this takes a few seconds.

Corcept Therapeutics (CORT)

NasdaqCM: CORT · 即時價格 · USD

114.92

-0.78 (-0.67%)

收盤價： Sep 10, 2026, 3:59 PM

提醒

Alert

股價、關鍵數字和最新消息，都在這一頁。

-0.67% (1D)

買價	90.56
市值	12.6B
營收 (ttm)	831M
淨利（ttm）	54.3M
	0.45
	0.45
	259.6
	26.53
P/B (ttm)	17.86
P/S (ttm)	15.20
財報日期	Nov 4, 2026

賣價	139.2
成交量	675,995
20 日平均成交量	1,065,401
開盤價	114.42
前收盤價	115.70
當日區間	113.20 - 116.97
52 週範圍	28.66 - 126.38
分析師	n/a
目標價	n/a
股利	n/a
除息日	n/a

關於 CORT

Corcept Therapeutics Incorporated, a biopharmaceutical company, engages in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States. The company offers Korlym, an oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome who have type 2 diabetes mellitus or glucose intolerance and have...

[閱讀更多]

產業 Biotechnology

類股 Healthcare

IPO 日期 Apr 14, 2004

員工 730

證券交易所 NasdaqCM

股票代號 CORT

網站 https://www.corcept.com

完整的公司簡介

財務表現

Corcept Therapeutics 在 2025 年的營收為 761.41M，較前一年的 675.04M 增加 12.79%。淨利為 99.65M，較前期減少 -29.43%。

財務報表

財報驚奇

Corcept Therapeutics 已於 Jul 29, 2026 公布季度財報：

營收為 $256.15M 低於預期 $0, 年增 31.74% 成長.
每股盈餘為 0.36 超出預期 0.30, 年增 24.14% 成長.

下次財報發布

Corcept Therapeutics 的下次財報預計於 Nov 4, 2026, 盤中。
分析師預估營收 ... 升級

價格為何變動

新聞動態

6 天前 · Stocktwits

BE, P, ILMN Join S&P 500; LNG Misses Out — Bloom Energy Stock Gains While Cheniere Energy Slips

S&P said on Friday that Bloom Energy, Everpure (P) and Illumina (ILMN) will join the S&P 500 index.

6 天前 · Zacks

United Therapeutics (UTHR) Down 8% Since Last Earnings Report: Can It Rebound?

United Therapeutics (UTHR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

1 週前 · StockStory

1 Growth Stock Set to Flourishand 2 We Brush Off

Growth is a hallmark of all great companies, but the laws of gravity eventually take hold. Those who rode the COVID boom and ensuing tech selloff in 2022 will surely remember that the market’s punishm...

1 週前 · Zacks

Why Is Corcept (CORT) Down 1.2% Since Last Earnings Report?

Corcept (CORT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

2 週前 · StockStory

1 Mid-Cap Stock for Long-Term Investors and 2 That Underwhelm

Mid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large addressable markets. But the many opportunities in front of them attract si...

第 1 頁，共 2 頁

Corcept Therapeutics (CORT)